Aio 001 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aio 001. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aio 001 Today - Breaking & Trending Today
GSK plc is plunking down $1 billion cash to take over Aiolos Bio Inc., with the promise of as much as $400 million in regulatory milestone payments along with tiered royalties. The deal gives London-based GSK asthma candidate AIO-001, a phase II-ready, long-acting antibody that binds to the human thymic stromal lymphopoietin (TSLP) ligand to inhibit TSLP signaling and relieve inflammation. GSK said AIO-001 could redefine the standard of care in asthma via the prospect of dosing every six months. ....